Alexion Pharmaceuticals

ALXN

113.09

-0.45

-0.4%

After Hours:

113.09

0.00

0.0%

Please Login or Register

Login|Register FREE

Stock Price
Open: 114.01
Prev. Close: 113.54
Low/Hi: 111.80 - 114.55
52-Week: 96.18 - 149.34
Volumes
Equity: 1,609,126
90-Day Avg: 1,912,963
Option: 1,327
90-Day Avg: 3,104
Volatility
Todays Stock Vol: 24.9
20-Day (HV): 32.8
52-Week (HV): 30.7
30-Day IV: 36.7 +2.1
IV Pct Rank: 66% Moderate
Fundamental
Div. Yield:
Earnings: 8-Feb (Est.)
P/E Ratio: 50.46
Market Cap: 25.4 B
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

ALXN Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Sep-2017 30-Jun-2017 31-Mar-2017 31-Dec-2016
Cash and Cash Equivalents 550,000 542,000 713,000 966,000
Short Term Investments 979,000 902,000 749,000 327,000
Investments - - - -
Accounts Receivable 705,000 710,000 660,000 650,000
Inventory 441,000 410,000 396,000 375,000
Loans - - - -
Prepaid Expenses 207,000 225,000 215,000 260,000
Net Property Plant and Equipment 1,354,000 1,233,000 1,138,000 1,036,000
Other Current Assets 0 0 0 0
Current Assets 2,882,000 2,789,000 2,733,000 2,578,000
Goodwill and Intangibles 9,069,000 9,149,000 9,260,000 9,340,000
Long Term Investments 0 0 0 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 13,643,000 13,489,000 13,435,000 13,253,000
Short Term Debt 0 0 0 0
Other Non-Current Assets 338,000 318,000 304,000 299,000
Accounts Payable 35,000 51,000 61,000 64,000
Accrued Liabilities and Other Payables 703,000 562,000 546,000 508,000
Long Term Debt 3,096,000 3,081,000 3,116,000 2,888,000
Other Liabilities - - - -
Current Portion of Long Term Debt 167,000 167,000 167,000 167,000
Total Liabilities 4,699,000 4,614,000 4,579,000 4,559,000
Other Current Liabilities 67,000 76,000 63,000 84,000
Accumulated Other Comprehensive Income -37,000 -14,000 36,000 60,000
Preferred Stock 0 0 0 0
Current Liabilities 972,000 856,000 837,000 823,000
Common Stock 0 0 0 0
Other Non-Current Liabilities 631,000 677,000 626,000 848,000
Additional Paid-In Capital 8,209,000 8,135,000 8,060,000 7,957,000
Treasury Stock -1,440,000 -1,380,000 -1,209,000 -1,141,000
Other Equity 0 0 0 0
Retained Earnings 2,212,000 2,134,000 1,969,000 1,818,000
Total Equity 8,944,000 8,875,000 8,856,000 8,694,000
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Cash and Cash Equivalents 966,000 1,010,111 943,999 529,857
Short Term Investments 327,000 374,904 1,017,567 984,994
Investments - - - -
Accounts Receivable 650,000 532,832 432,888 421,752
Inventory 375,000 289,874 176,441 102,602
Loans - - - -
Prepaid Expenses 260,000 217,628 189,401 106,220
Net Property Plant and Equipment 1,036,000 697,025 392,248 201,109
Other Current Assets 0 0 35,733 41,432
Current Assets 2,578,000 2,425,349 2,796,029 2,186,857
Goodwill and Intangibles 9,340,000 9,755,799 841,119 863,792
Long Term Investments 0 0 0 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 13,253,000 13,133,230 4,201,962 3,317,696
Short Term Debt 0 0 0 0
Other Non-Current Assets 299,000 255,057 172,566 65,938
Accounts Payable 64,000 57,360 44,016 21,596
Accrued Liabilities and Other Payables 508,000 403,348 395,232 402,344
Long Term Debt 2,888,000 3,281,250 116,599 97,230
Other Liabilities - - - -
Current Portion of Long Term Debt 167,000 175,000 48,000 48,000
Total Liabilities 4,559,000 4,874,614 899,944 935,617
Other Current Liabilities 84,000 82,542 119,492 110,489
Accumulated Other Comprehensive Income 60,000 62,301 56,785 -22,857
Preferred Stock 0 0 0 0
Current Liabilities 823,000 718,250 606,740 582,429
Common Stock 0 23 20 20
Other Non-Current Liabilities 848,000 875,114 176,605 255,958
Additional Paid-In Capital 7,957,000 7,726,560 2,592,167 2,106,183
Treasury Stock -1,141,000 -710,663 -382,964 -80,365
Other Equity 0 0 0 0
Retained Earnings 1,818,000 1,180,395 1,036,010 379,098
Total Equity 8,694,000 8,258,616 3,302,018 2,382,079

Wait, Before You Leave...